Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-08-06

FDA Approved: OLOPATADINE HYDROCHLORIDE — Supplemental Application (Apotex Corp.)

View source ↗

Summary

FDA approved a supplemental application from Apotex Corp. for olopatadine hydrochloride (generic ophthalmic antihistamine). The approval covers its use in treat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OLOPATADINE HYDROCHLORIDE (olopatadine hydrochloride)

Snippet

SUPPL AP for OLOPATADINE HYDROCHLORIDE (OLOPATADINE HYDROCHLORIDE)